- Home
- HYLN vs MRVI Comparison
HYLN vs MRVI Comparison
Compare HYLN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYLN
- MRVI
- Stock Information
- Founded
- HYLN 2018
- MRVI 2014
- Country
- HYLN United States
- MRVI United States
- Employees
- HYLN N/A
- MRVI N/A
- Industry
- HYLN Construction/Ag Equipment/Trucks
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- HYLN Consumer Discretionary
- MRVI Health Care
- Exchange
- HYLN Nasdaq
- MRVI Nasdaq
- Market Cap
- HYLN 279.7M
- MRVI 312.4M
- IPO Year
- HYLN N/A
- MRVI 2020
- Fundamental
- Price
- HYLN $1.45
- MRVI $2.67
- Analyst Decision
- HYLN Hold
- MRVI Hold
- Analyst Count
- HYLN 1
- MRVI 10
- Target Price
- HYLN $2.00
- MRVI $6.84
- AVG Volume (30 Days)
- HYLN 967.9K
- MRVI 1.9M
- Earning Date
- HYLN 08-05-2025
- MRVI 08-06-2025
- Dividend Yield
- HYLN N/A
- MRVI N/A
- EPS Growth
- HYLN N/A
- MRVI N/A
- EPS
- HYLN N/A
- MRVI N/A
- Revenue
- HYLN $1,998,000.00
- MRVI $241,856,000.00
- Revenue This Year
- HYLN $741.55
- MRVI N/A
- Revenue Next Year
- HYLN $185.14
- MRVI $10.62
- P/E Ratio
- HYLN N/A
- MRVI N/A
- Revenue Growth
- HYLN 451.93
- MRVI N/A
- 52 Week Low
- HYLN $1.11
- MRVI $1.67
- 52 Week High
- HYLN $4.10
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- HYLN 49.53
- MRVI 67.02
- Support Level
- HYLN $1.31
- MRVI $2.32
- Resistance Level
- HYLN $1.50
- MRVI $2.72
- Average True Range (ATR)
- HYLN 0.09
- MRVI 0.15
- MACD
- HYLN -0.00
- MRVI 0.05
- Stochastic Oscillator
- HYLN 42.86
- MRVI 92.36
About HYLN Hyliion Holdings Corp.
Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.